MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    CLINICAL AND GENEOLOGICAL FEATURES OF PARKINSON’S DISEASE

    S. Kuranbaeva, S. Kalandarova, A. Umarov, G. Goyibova (Tashkent, Uzbekistan)

    Objective: The initial purpose of the work is to study the clinical and genealogical features of Parkinson's disease. Background: Currently, clinical genetics has a number…
  • 2022 International Congress

    Long-term Safety of Medical Cannabis in Parkinson’s disease: a retrospective case-control study

    T. Goldberg, Y. Redlich, T. Fay-Karmon, S. Hassin-Baer, S. Anis (Tel Aviv, Israel)

    Objective: This study aims to evaluate the effects of long-term treatment with medical cannabis (MC) on the course of Parkinson’s disease (PD), with a focus…
  • 2022 International Congress

    Machine learning algorithms for classification and analysis of pen-on-paper Archimedes spirals

    R. Anandapadmanabhan, A. Vishnoi, D. Biswas, A. Srivastava, D. Joshi, A. Mahabal, R. Rajan (New Delhi, India)

    Objective: To classify tremor syndromes from freely hand drawn pen-on-paper Archimedes spirals using classical machine learning techniques. Background: Spiral drawings (Archimedean) are commonly used in…
  • 2022 International Congress

    A low-cost system using a big-data deep-learning framework for assessing physical tele-rehabilitation: a proof-of-concept

    A. Olivares-Gil, JM. Ramírez-Sanz, JL. Garrido-Labrador, á. García-Bustillo, á. Arnaiz-González, JF. Díez-Pastor, J. González-Santos, JJ. González-Bernal, M. Allende-Río, F. Valiñas-Sieiro, JM. Trejo-Gabriel-Galan, E. Cubo (Burgos, Spain)

    Objective: The consolidation of tele-rehabilitation for the treatment of many diseases over the last decades is a result of its cost-effective results and its ability…
  • 2022 International Congress

    Botulinum toxin injections are an effective treatment for patients with essential head tremor.

    A. Marques, I. Rieu, B. Pereira, G. Castelnovo, F. Fluchère, C. Laurencin, B. Degos, A. Poujois, A. Kreisler, S. Sangla, M. Tir, I. Benatru, G. Blanchet-Fourcade, D. Guehl, D. Gayraud, L. Tatu, C. Tranchant, D. Amarantini, M. Simonetta, F. Durif (Clermont-Ferrand, France)

    Objective: To assess the safety and efficacy of Botulinum toxin (Btx) injections in essential head tremor (HT) in a multicenter, randomized, double blind, parallel-group, placebo-controlled…
  • 2022 International Congress

    Gait and Balance Characteristics in Atypical Parkinsonian Syndromes

    V. Sidoroff, C. Raccagni, K. Seppi, H. Gassner, J. Winkler, N. Hergenröder-Lenzner, N. Roth, B. Eskofier, S. Buechner, D. Benninger, K. Aminian, G. Wenning (Innsbruck, Austria)

    Objective: To characterize a cohort of patients with multiple system atrophy (MSA) and progressive supranuclear gaze palsy compared to idiopathic Parkinson’s disease (IPD) patients according…
  • 2022 International Congress

    GPi-DBS induced brain metabolic activation in cervical dystonia

    EA. Honkanen, J. Korpela, E. Pekkonen, J. Aaltonen, M. Koivu, O. Eskola, H. Eldebakey, J. Volkmann, V. Kaasinen, MM. Reich, J. Joutsa (Turku, Finland)

    Objective: To investigate the effects of GPi-DBS on brain glucose metabolism locally at the stimulation site and across the whole brain in patients with cervical…
  • 2022 International Congress

    Long non-coding RNAs in Parkinson’s disease: bringing back life to the grey matter?

    S. Acharya, A. Lumley, L. Zhang, V. Stopa, Y. Devaux (Strassen, Luxembourg)

    Objective: Our study aims to discover and delineate the role of novel long non-coding RNAs (lncRNAs) in Parkinson’s disease (PD). Background: LncRNAs have been widely…
  • 2022 International Congress

    The mitochondrial risk score and lifestyle factors are associated with age at onset in LRRK2 p.Gly2019Ser Parkinson’s disease.

    T. Lüth, C. Gabbert, P. Lajer, I. König, A. Caliebe, S. Koch, B-H. Laabs, F. Hentati, S. Sassi, R. Amouri, C. Klein, A. Grünewald, M. Farrer, J. Trinh (Lübeck, Germany)

    Objective: To investigate the relationship between a mitochondrial risk score (MRS), lifestyle and age at onset (AAO) in LRRK2 G2019S Parkinson’s disease (PD). Background: PD…
  • 2022 International Congress

    Importance of lifestyle advice for participants in studies of early Parkinson’s disease

    F. Fuchs, I. Tödt, A. Rogge, J. Naumann, D. Berg, E. Schäffer (Kiel, Germany)

    Objective: Estimating the ethical acceptability of early Parkinson’s Disease (PD) research among healthy individuals participating in a PD screening study in terms of risk disclosure…
  • « Previous Page
  • 1
  • …
  • 453
  • 454
  • 455
  • 456
  • 457
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley